Partner Headlines - ILMN

  1. Making Money With Charles Payne: 09/26/14

    FoxBusiness
  2. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD
  3. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD
  4. Sigma-Aldrich Hits High On Sale To Germany's Merck

    IBD
  5. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  6. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  7. Does Illumina's Latest Base Have The Profit Gene?

    IBD
  8. Quiet Stocks Are Typical In Market Right Now

    IBD
  9. IBD 50 Showing Little Distress, But Few Big Winners

    IBD
  10. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  11. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD
  12. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  13. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  14. Illumina Joins Drugmakers To Make Cancer Test System

    IBD
  15. Illumina: Making Markets By Unlocking The Genome

    IBD
  16. Illumina lines up key partners

    IBD
  17. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  18. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  19. US Stock Futures Surge Ahead Of Economic Data

    Benzinga
  20. Markets Mostly Higher Despite Initial Negative Reaction From ...

    Benzinga
  21. Wedbush Upgrades Illumina To Outperform, Shares Rise

    Benzinga
  22. Stocks Shave Down Early Losses; Spirit Airlines, Illumina Climb

    IBD
  23. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  24. UPDATE: Stifel Nicolaus Initiates Coverage on Illumina, Inc. ...

    Benzinga
  25. Benzinga's Top Initiations

    Benzinga
  26. Stifel Nicolaus Initiates Illumina At Buy

    Benzinga
  27. Stocks Hold Gains Midday; Walgreen Recoups Losses

    IBD
  28. UPDATE: Tigress Initiates Coverage On Illumina

    Benzinga
  29. Top Insider Sells Highlight: Illumina Inc.

    GuruFocus
  30. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  31. Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine

    IBD
  32. Under Armour, Facebook Soar As Nasdaq Turns Positive

    IBD
  33. Illumina reports robust Q2

    IBD
  34. Stocks Open Low And Soft; Baidu, Kandi, Diamonback Rise

    IBD
  35. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  36. Illumina Names Tina S. Nova As Senior Vice Pres And General Manager ...

    Benzinga
  37. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  38. Several Big Cap 20 Names Near Buy Points

    IBD
  39. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  40. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  41. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  42. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  43. Novo, Other Medicals Display Healthy Action

    IBD
  44. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  45. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  46. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  47. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  48. Stocks Build On Gains Backed By Strong Volume

    IBD
  49. Stocks Show Solid Gains At Midday

    IBD
  50. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  51. Five Star Biotech Stock Watch: Illumina

    Benzinga
  52. Baron Funds Comments on Illumina Inc.

    GuruFocus
  53. Baron Funds Comments on Illumina Inc.

    GuruFocus
  54. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  55. Baron Funds Comments on Illumina Inc.

    GuruFocus
  56. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  57. Illumina Reports Filing of New Patent Infringement Case Against ...

    Benzinga
  58. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  59. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  60. Gilead, Illumina Crush Views

    IBD
  61. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  62. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  63. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  64. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  65. Medical Research Providers Ride Higher With Biotechs

    IBD
  66. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  67. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  68. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  69. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  70. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  71. ILLUMINA

    IBD
  72. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  73. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  74. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  75. Illumina Announces New Organizational Alignment -8K

    Benzinga
  76. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  77. ILLUMINA

    IBD
  78. Illumina Upbeat On Q4, 2014

    IBD
  79. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  80. Year in Review: 2013 Innovations

    FoxBusiness
  81. Year in Review: 2013 Innovations

    FoxBusiness
  82. Benzinga's Top Initiations

    Benzinga
  83. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  84. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  85. Illumina Appoints Francis deSouza as President

    Benzinga
  86. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement ...

    Benzinga
  87. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  88. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing ...

    Benzinga
  89. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  90. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  91. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  92. Illumina Tops Q3 Profit, Sales

    IBD
  93. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  94. Earnings Scheduled For October 21, 2013

    Benzinga
  95. Illumina Collaborates with University of Cambridge, Genomics ...

    Benzinga
  96. Illumina's Verinata Health Reports Expanded Test of Verifi for ...

    Benzinga
  97. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  98. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  99. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  100. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 ...

    Benzinga
Trading Center